全文获取类型
收费全文 | 1988篇 |
免费 | 199篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 121篇 |
妇产科学 | 15篇 |
基础医学 | 283篇 |
口腔科学 | 13篇 |
临床医学 | 235篇 |
内科学 | 492篇 |
皮肤病学 | 32篇 |
神经病学 | 135篇 |
特种医学 | 152篇 |
外科学 | 202篇 |
综合类 | 36篇 |
一般理论 | 1篇 |
预防医学 | 224篇 |
眼科学 | 16篇 |
药学 | 119篇 |
中国医学 | 10篇 |
肿瘤学 | 100篇 |
出版年
2021年 | 23篇 |
2019年 | 19篇 |
2018年 | 30篇 |
2017年 | 14篇 |
2016年 | 19篇 |
2015年 | 41篇 |
2014年 | 25篇 |
2013年 | 59篇 |
2012年 | 72篇 |
2011年 | 79篇 |
2010年 | 52篇 |
2009年 | 53篇 |
2008年 | 65篇 |
2007年 | 64篇 |
2006年 | 79篇 |
2005年 | 70篇 |
2004年 | 72篇 |
2003年 | 57篇 |
2002年 | 52篇 |
2001年 | 51篇 |
2000年 | 55篇 |
1999年 | 62篇 |
1998年 | 49篇 |
1997年 | 62篇 |
1996年 | 60篇 |
1995年 | 54篇 |
1994年 | 37篇 |
1993年 | 31篇 |
1992年 | 46篇 |
1991年 | 51篇 |
1990年 | 41篇 |
1989年 | 48篇 |
1988年 | 61篇 |
1987年 | 51篇 |
1986年 | 47篇 |
1985年 | 38篇 |
1984年 | 20篇 |
1983年 | 34篇 |
1982年 | 23篇 |
1981年 | 26篇 |
1980年 | 19篇 |
1979年 | 22篇 |
1978年 | 18篇 |
1977年 | 19篇 |
1976年 | 18篇 |
1975年 | 24篇 |
1972年 | 14篇 |
1971年 | 16篇 |
1970年 | 21篇 |
1969年 | 13篇 |
排序方式: 共有2189条查询结果,搜索用时 0 毫秒
101.
Leo Jeng Alexandra V Yamshchikov Suzanne E Judd Henry M Blumberg Gregory S Martin Thomas R Ziegler Vin Tangpricha 《Journal of translational medicine》2009,7(1):28
Background
Vitamin D insufficiency is common in hospitalized patients. Recent evidence suggests that vitamin D may enhance the innate immune response by induction of cathelicidin (LL-37), an endogenous antimicrobial peptide produced by macrophages and neutrophils. Thus, the relationship between vitamin D status and LL-37 production may be of importance for host immunity, but little data is available on this subject, especially in the setting of human sepsis syndrome and other critical illness. 相似文献102.
103.
Ushma Mehta David Durrheim Aaron Mabuza Lucille Blumberg Elizabeth Allen Karen I Barnes 《Drug safety》2007,30(10):899-910
BACKGROUND AND OBJECTIVES: Prior to the introduction of artemisinin-based combination antimalarial therapy in Mpumalanga province, South Africa, a pharmacovigilance strategy was developed to pilot locally relevant surveillance methods for detecting serious adverse drug reactions (ADRs) and signals related to artesunate plus sulfadoxine/pyrimethamine. STUDY DESIGN: From 1 March 2002 to 30 June 2004, five methods for detecting ADRs in patients receiving antimalarials were piloted in the rural communities of Mpumalanga province in South Africa: (i) home follow-up of patients by malaria control staff; (ii) enhanced spontaneous reporting of suspected ADRs by health professionals at clinics and hospitals; (iii) active hospital surveillance for malaria-related admissions and patients recently treated for malaria; (iv) a confidential enquiry into malaria-related deaths; and (v) adverse events monitoring during two therapeutic efficacy studies conducted in 2002 and 2004. RESULTS: During the study period, the malaria control programme was notified of 4778 cases of malaria while sulfadoxine/pyrimethamine monotherapy was the recommended treatment and 7692 cases after the introduction of artesunate plus sulfadoxine/pyrimethamine in January 2003. Of 2393 home follow-up visits of reported cases of malaria, three fatal adverse events were identified where recent use of artesunate plus sulfadoxine/pyrimethamine treatment was reported. Two cases were attributed to poor response to treatment, while one case was considered possibly related to artesunate plus sulfadoxine/pyrimethamine treatment. Clinic and hospital surveillance reported six ADRs in association with sulfadoxine/pyrimethamine treatment, five being treatment failures and one being a non-serious rash. During active hospital surveillance, 38 inpatients exposed to sulfadoxine/pyrimethamine were identified, including one child who experienced pancytopenia following treatment with sulfadoxine/pyrimethamine 11 days before admission; this adverse effect was considered to be possibly due to sulfadoxine/pyrimethamine treatment. The confidential enquiry into malaria-related deaths identified three adverse events, including a death where the contribution of treatment could not be excluded. A therapeutic efficacy study of 95 patients followed over 42 days identified one case of repeated vomiting possibly associated with artesunate plus sulfadoxine/pyrimethamine. CONCLUSION: Multifaceted monitoring throughout the malaria patient journey is necessary in developing countries implementing new treatments to safeguard against missing serious complications associated with malaria treatment. 相似文献
104.
105.
Rong SB Enyedy IJ Qiao L Zhao L Ma D Pearce LL Lorenzo PS Stone JC Blumberg PM Wang S Kozikowski AP 《Journal of medicinal chemistry》2002,45(4):853-860
The Ras guanyl releasing protein RasGRP belongs to the CDC25 class of guanyl nucleotide exchange factors that regulate Ras-related GTPases. These GTPases serve as switches for the propagation and divergence of signaling pathways. One interesting feature of RasGRP is the presence of a C-terminal C1 domain, which has high homology to the PKC C1 domain and binds to diacylglycerol (DAG) and phorbol esters. RasGRP thus represents a novel, non-kinase phorbol ester receptor. In this paper, we investigate the binding of indolactam(V) (ILV), 7-(n-octyl)-ILV, 8-(1-decynyl)benzolactam(V) (benzolactam), and 7-methoxy-8-(1-decynyl)benzolactam(V) (methoxylated benzolactam) to RasGRP through both experimental binding assays and molecular modeling studies. The binding affinities of these lactams to RasGRP are within the nanomolar range. Homology modeling was used to model the structure of the RasGRP C1 domain (C1-RasGRP), which was subsequently used to model the structures of C1-RasGRP in complex with these ligands and phorbol 13-acetate using a computational docking method. The structural model of C1-RasGRP exhibits a folding pattern that is nearly identical to that of C1b-PKCdelta and is comprised of three antiparallel-strand beta-sheets capped against a C-terminal alpha-helix. Two loops A and B comprising residues 8-12 and 21-27 form a binding pocket that has some positive charge character. The ligands phorbol 13-acetate, benzolactam, and ILV are recognized by C1-RasGRP through a number of hydrogen bonds with loops A and B. In the models of C1-RasGRP in complex with phorbol 13-acetate, benzolactam, and ILV, common hydrogen bonds are formed with two residues Thr12 and Leu21, whereas other hydrogen bond interactions are unique for each ligand. Furthermore, our modeling results suggest that the shallower insertion of ligands into the binding pocket of C1-RasGRP compared to C1b-PKCdelta may be due to the presence of Phe rather than Leu at position 20 in C1-RasGRP. Taken together, our experimental and modeling studies provide us with a better understanding of the structural basis of the binding of PKC ligands to the novel phorbol ester receptor RasGRP. 相似文献
106.
107.
The World Health Organization estimates that more than 300 million cases of malaria exist worldwide each year, resulting in more than 3 million deaths, with more than 1 million deaths of children in sub-Saharan Africa alone. Malaria is also a reemerging disease in some parts of Africa, including South Africa. Malaria prevention is multi-faceted with no single precaution offering complete protection. Taking chemoprophylaxis decreases the severity and frequency of death from malaria due to Plasmodium falciparum when compared with taking no chemoprophylaxis. 相似文献
108.
109.
Effects of antihypertensive drugs on ultrasound production and cardiovascular responses in 15-day-old rats 总被引:1,自引:0,他引:1
When exposed to extreme cold or injected with the alpha(2)-adrenoceptor agonist, clonidine, infant rats emit ultrasonic vocalizations (USVs). Based upon the cardiovascular changes that accompany these two manipulations, especially decreased venous return, it was hypothesized that USVs are the acoustic by-product of the abdominal compression reaction (ACR), a maneuver that increases venous return. If this hypothesis is correct, then other anithypertensive drugs that decrease venous return should evoke USVs. In Experiment 1, sodium nitroprusside (SNP, 400 microg/kg), a direct-acting dilator of arteries and veins, was administered to 15-day-old rats under thermoneutral conditions while cardiac rate and ultrasound production were monitored. In Experiment 2, femoral artery pressure was monitored after SNP administration. Infants responded to SNP administration with decreased arterial pressure and tachycardia and, in addition, significantly increased ultrasound production. In Experiment 3, chlorisondamine (5 mg/kg), a ganglionic blocker that causes vasodilation and bradycardia, and hydralazine (20 mg/kg), a selective dilator of arteries, was administered to 15-day-olds. As predicted, chlorisondamine evoked ultrasound production and hydralazine did not. These results introduce SNP and chlorisondamine as only the second and third known agents capable of independently evoking USVs in thermoneutral conditions, and provide further support for the notion that ultrasound production is triggered by decreased venous return. 相似文献
110.
Theresa L Antoine Amy B Curtis Henry M Blumberg Kathryn Desilva Mesfin Fransua Carolyn V Gould Mark King Alice A Kraman Jan Pack Bruce Ribner Ulrich Seybold James P Steinberg Jane B Wells Ronda L Sinkowitz-Cochran Denise Cardo John A Jernigan Robert P Gaynes 《Infection control and hospital epidemiology》2006,27(11):1274-1277
We investigated knowledge, attitudes, and behaviors of prescribers concerning piperacillin-tazobactam use at 4 Emory University-affiliated hospitals. Discussions during focus groups indicated that the participants' perceived knowledge of clinical criteria for appropriate piperacillin-tazobactam use was inadequate. Retrospective review of medical records identified inappropriate practices. These findings have influenced ongoing interventions aimed at optimizing piperacillin-tazobactam use. 相似文献